Trials / Completed
CompletedNCT00233740
Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)
The Cordis Protection From Pulmonary Embolism With the Permanent OptEase™ Filter - A Post Marketing Surveillance Study (PROOF Study)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (planned)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to monitor the safety and effectiveness of the OptEase™ Permanent Vena Cava (IVC) Filter
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OPTEASE Vena Cava Filter |
Timeline
- Start date
- 2003-09-01
- Completion
- 2005-05-01
- First posted
- 2005-10-06
- Last updated
- 2008-08-05
Source: ClinicalTrials.gov record NCT00233740. Inclusion in this directory is not an endorsement.